Skip to main content
Signal8
WASSON GREGORY D profile photo

Gregory D. Wasson

CIK: 0001188827

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

OptimizeRx Corp logo
OPRX

OptimizeRx Corp

Director
P3 Health Partners Inc. logo
PIII

P3 Health Partners Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • OptimizeRx Corp logo
    OPRX

    OptimizeRx Corp

    Jun 9, 2026
    Award(A)
    Direct
    34.5K shares-
  • P3 Health Partners Inc. logo
    PIII

    P3 Health Partners Inc.

    Aug 6, 2025
    Award(A)
    Direct
    2K shares-
  • P3 Health Partners Inc. logo
    PIII

    P3 Health Partners Inc.

    Aug 6, 2025
    Award(A)
    Direct
    2K shares-
  • OptimizeRx Corp logo
    OPRX

    OptimizeRx Corp

    Jun 11, 2025
    Award(A)
    Direct
    9.9K shares-

1-4 of 4

About WASSON GREGORY D

WASSON GREGORY D (SEC CIK 0001188827) files insider reports with the SEC as Director of OptimizeRx Corp (OPRX) and Director of P3 Health Partners Inc. (PIII).

Signal8 holds 4 ownership filings by WASSON GREGORY D, all Form 4s, filed between Jun 12, 2025 and Jun 10, 2026. Those filings report 4 transactions, from Jun 11, 2025 to Jun 9, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on WASSON GREGORY D's filings is in WALTHAM, MA.

Recent filings by WASSON GREGORY D

  • Jun 9, 2026: Grant or award of OPRX shares (Form 4, code A).
  • Aug 6, 2025: Grants or awards of PIII shares (2 lines, Form 4, code A).
  • Jun 11, 2025: Grant or award of OPRX shares (Form 4, code A).

Other insiders filing for OptimizeRx Corp (OPRX)

How to read Form 4 transaction codes